NCT02400801View on ClinicalTrials.gov

Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients

NACompletedINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

January 26, 2018

Conditions

EndometriosisInfertility

Interventions

DRUG

triptorelin

gonadotropin-releasing hormone (GnRH) agonist

DRUG

ethinylestradiol + dienogest

oral oestroprogestogen

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02400801 - Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients | Biotech Hunter | Biotech Hunter